quinidine has been researched along with Central Nervous System Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jahrmärker, H; Theisen, K | 1 |
| Morganroth, J | 1 |
| Bleifeld, W; Effert, S; Merx, W | 1 |
| Abildskov, JA; Burgess, MJ | 1 |
2 review(s) available for quinidine and Central Nervous System Disease
| Article | Year |
|---|---|
[Re-entry mechanism of ventricular tachycardias in inhomogenic repolarization. With special reference to Jervell-Lange-Nielsen syndrome and similar states and their therapy].
Topics: Arrhythmias, Cardiac; Arteriosclerosis; Cardiac Glycosides; Central Nervous System Diseases; Coronary Disease; Deafness; Electrocardiography; Heart; Heart Conduction System; Heart Diseases; Heart Ventricles; Humans; Hypokalemia; Hypoxia; Quinidine; Syncope; Syndrome; Tachycardia | 1975 |
Neurogenic abnormalities of ventricular repolarization.
Topics: Animals; Arrhythmias, Cardiac; Autonomic Nervous System; Bradycardia; Central Nervous System Diseases; Coronary Disease; Diagnosis, Differential; Dogs; Electric Stimulation; Electrocardiography; Heart; Heart Diseases; Heart Ventricles; Hemodynamics; Humans; Nervous System Diseases; Quinidine; Stellate Ganglion; Sympathetic Nervous System; Ventricular Fibrillation | 1971 |
1 trial(s) available for quinidine and Central Nervous System Disease
| Article | Year |
|---|---|
Comparative efficacy and safety of oral mexiletine and quinidine in benign or potentially lethal ventricular arrhythmias.
Topics: Administration, Oral; Arrhythmias, Cardiac; Central Nervous System Diseases; Clinical Trials as Topic; Electrocardiography; Female; Gastrointestinal Diseases; Humans; Male; Mexiletine; Quinidine | 1987 |
1 other study(ies) available for quinidine and Central Nervous System Disease
| Article | Year |
|---|---|
[Clinical pharmacology and adverse effects of various anti-arrhythmic drugs].
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Bone Marrow Diseases; Central Nervous System Diseases; Female; Gastrointestinal Diseases; Heart Diseases; Hemodynamics; Humans; Imidazoles; Isoproterenol; Lidocaine; Membrane Potentials; Phenytoin; Plants, Medicinal; Procainamide; Quinidine; Rauwolfia; Verapamil | 1971 |